Comparison of 27-Gauge to 25-Gauge Vitrectomy in Patients with Tractional Retinal Detachment Associated with Proliferative Diabetic Retinopathy
- PMID: 40217982
- PMCID: PMC11989642
- DOI: 10.3390/jcm14072533
Comparison of 27-Gauge to 25-Gauge Vitrectomy in Patients with Tractional Retinal Detachment Associated with Proliferative Diabetic Retinopathy
Abstract
Background/Objectives: To compare the surgical outcomes of 25-gauge (G) vitrectomy to those of 27G vitrectomy for proliferative diabetic retinopathy (PDR) with a tractional retinal detachment (TRD). Methods: Eighty-three consecutive eyes of 71 patients with PDR and TRD that underwent initial vitrectomy at the Kyorin Eye Center from June 2021 to August 2023 and were followed for ≥3 months were studied retrospectively. The surgical outcomes of the 10,000 cut/min (cpm) 25G vitrectomy (25G group, 25 eyes) to that of the 20,000 cpm 27G vitrectomy (27G group, 58 eyes) were compared. Results: The preoperative PDR status, surgical procedures, and postoperative outcomes were assessed relative to the surgical success. The 25G group had significantly more eyes with severe PDR (p = 0.010), no prior laser photocoagulation (p = 0.027), macular detachment (p = 0.006), and the use of bimanual technique (p = 0.005). However, the operative times and incidence of iatrogenic breaks were not significantly different. The visual acuity improved significantly in both groups at 3 months postoperatively. The primary anatomical success was 88% in the 25G and 97% in the 27G groups (p > 0.05). The risk factors for a postoperative retinal detachment were significantly associated with the grade (p = 0.042) and type of PDR (p = 0.041), the use of perfluorocarbon liquid (p = 0.028), and bimanual techniques (p = 0.017). Conclusions: The high anatomical success for both groups for TRD secondary to PDR indicates that both can be used to treat eyes with PDR. The 27G vitrectomy may reduce the need for bimanual techniques.
Keywords: 25-gauge; 27-gauge; proliferative diabetic retinopathy; tractional retinal detachment; twin duty cycle; vitrectomy.
Conflict of interest statement
H.O., T.T., T.Y.: no disclosures, J.T.: received a research grant from AMO Japan K.K and personal fees (lecture fees) from Novartis Pharma K.K., Santen Pharmaceutical Co., Ltd., Bayer AG, Novartis Pharma K.K., SENJU Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., outside the submitted work. T.K. received research grants from Ellex and Alcon Laboratories, Inc. and personal fees (lecture fees) from Alcon Laboratories, Inc., Novartis Pharma K.K., Bayer AG, Carl Zeiss Meditec AG, Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co., Ltd., AMO., outside the submitted work. M.I. received grants from Alcon Laboratories, Inc. and Santen Pharmaceutical Co., Ltd. and personal fees (lecture fees) from Santen Pharmaceutical Co., Ltd., Bayer AG, Novartis Pharma K.K., SENJU Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd. Alcon Japan Ltd., Carl Zeiss Meditec, Logic and Design Inc., outside the submitted work.
Figures


Similar articles
-
Four-port bimanual 23-gauge vitrectomy for diabetic tractional retinal detachment.Acta Ophthalmol. 2016 Jun;94(4):365-72. doi: 10.1111/aos.12951. Epub 2016 Feb 8. Acta Ophthalmol. 2016. PMID: 26855122
-
Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy.Cochrane Database Syst Rev. 2023 May 31;5(5):CD008214. doi: 10.1002/14651858.CD008214.pub4. Cochrane Database Syst Rev. 2023. PMID: 37260074 Free PMC article. Review.
-
Comparison of 27-gauge and 25-gauge vitrectomy in the management of tractional retinal detachment secondary to proliferative diabetic retinopathy.PLoS One. 2021 Mar 25;16(3):e0249139. doi: 10.1371/journal.pone.0249139. eCollection 2021. PLoS One. 2021. PMID: 33765074 Free PMC article.
-
Surgical outcomes of 27-gauge and 25-gauge vitrectomy day surgery for proliferative diabetic retinopathy.Int Ophthalmol. 2019 Sep;39(9):1973-1980. doi: 10.1007/s10792-018-1030-z. Epub 2018 Oct 4. Int Ophthalmol. 2019. PMID: 30284092
-
A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.Ophthalmic Res. 2023;66(1):777-790. doi: 10.1159/000530231. Epub 2023 Mar 27. Ophthalmic Res. 2023. PMID: 36972566
References
-
- The Diabetic Retinopathy Vitrectomy Study Research Group Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. Ophthalmology. 1988;95:1321–1334. doi: 10.1016/S0161-6420(88)33014-9. - DOI - PubMed
-
- Khan M.A., Shahlaee A., Toussaint B., Hsu J., Sivalingam A., Dugel P.U., Lakhanpal R.R., Riemann C.D., Berrocal M.H., Regillo C.D., et al. Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease. Am. J. Ophthalmol. 2016;161:36–43.e2. doi: 10.1016/J.AJO.2015.09.024. - DOI - PubMed
LinkOut - more resources
Full Text Sources